Reinhard Vogt
Investing Profile
Sweet spot: $1.5M
Range: $100K–$5M
Dynamk Capital thesis
Portfolio News CONTACT US Scroll Funding the Future of Life Sciences News News February 24, 2026 bit.bio Accelerates Global Access to Human Cells with New Pricing Model and Distribution Hub February 24, 2026 Read more → February 24, 2026 December 11, 2025 Xcell Biosciences and Culture Biosciences Announce AI/ML Partnership for Cell Therapy December 11, 2025 Read more → December 11, 2025 October 8, 2025 Alpenglow Biosciences and Virdx Announce Strategic Deal to Advance AI-Enabled Prostate Cancer Diagnostics October 8, 2025 Read more → October 8, 2025 October 7, 2025 RoosterBio & Secretome Thera
Sector and stage focus
- Series B: Consumer Health, Health & Hospital Services, Digital Health, Health IT
- Series A: Consumer Health, Health IT, Health & Hospital Services, Digital Health
- Seed: Consumer Health, Health IT, Digital Health, Health & Hospital Services
- general: New York City
Is Reinhard Vogt a fit for your round?
Upload your pitch deck and see whether Reinhard Vogt appears in your top 20 matches.
Find investors for your deck